Please assess the completion status of the following clinical trial:

Trial Title: To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females aged between 18 and 65 years (inclusive)~2. Body Mass Index (BMI) is 27.0 to 45.0 kg/m2, inclusive~3. Able to give signed informed consent~4. Ambulatory and able to perform exercise program (Arena Healthy Lifestyle Program, see Appendix 1)~5. Eligible male and female patients must agree not to participate in a conception process~6. Considered to be in stable health in the opinion of the Investigator~Exclusion Criteria:~1. Prior participation in any study of lorcaserin.~2. Participants who are current smokers or have smoked within the previous 6 months. No smoking will be allowed during the study.~3. Clinically significant new illness in the 1 month before screening~4. Not suitable to participate in the study in the opinion of the Investigator including an existing physical or mental condition that prevents compliance with the protocol~5. Recent history (within 6 months before entering the study) of major depression, anxiety, or other psychiatric disease requiring treatment with prescription medication. SSRI's, SNRI's, and other medications must meet washout requirements.~6. Significant dislike or allergy to foods used during the food intake tests~7. History of any of the following cardiovascular conditions:~   * Myocardial infarction (diagnosed by cardiac enzyme\[s\] and/or diagnostic ECG), CVA, TIA or RIND within 3 months of screening; cardiac arrhythmia requiring medical or surgical treatment within 3 months of screening~  * Unstable angina~  * History of congestive heart failure caused by insufficiency, damage, or stenosis of any heart valve~  * History of pulmonary artery hypertension~8. Positive result of HIV, hepatitis B or hepatitis C screens~9. Recent treatment (i.e., within 1 month of the screening visit) with over-the-counter weight loss products or appetite suppressants (including herbal weight loss agents), or within 3 months with a prescription anti-obesity drug (e.g., phentermine, sibutramine, orlistat)~10. Participated in any clinical study with an investigational drug, biologic, or device within 1 month prior to screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo BID (Type: PLACEBO_COMPARATOR): None
- Lorcaserin 10mg BID (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).